Acne: FDA Approved Aczone For Acne Treatment

Related Links

Informative Articles

Acne Treatment, Finally Some Facts
Copyright 2005 George ForganSmith Acne is, perhaps, the single treated skin disorder and has been addressed in a wide variety of ways. Often the wisest step is to develop a program in consultation with a dermatologist or medical practitioner....

Male Breast Enlargement Products - Men's Options for Transgender Breast Enlargement
Transgender Breast Growth - Why Men Can Now Naturally Grow Breast Tissue Just Like Women Male to female breast enlargement and enhancement is gaining quite a bit of popularity these days. While it is true that most breast augmentations,...

Skin Care For Acne
Caring for your skin is important for good health and beauty, but especially so if you are prone to acne. One of the best ways to keep acne under control is to maintain your skin's health as much as possible. This means keeping the skin clean...

The Essential Oil Home Medicine Chest – Part I: The Oils
Essential oils provide a wonderful natural-medicine alternative to common ailments we see at home. Their actions are broad and diverse, ranging from topical antiseptics and anti-inflammatories to analgesics, digestive system tonics, and...

The First Step To Curing
The first step to curing acne is knowing what type of acne you have. This information gives you precious insight to what may have actually triggered the acne outset. Once you know your acne trigger, you are one step closer to removing the acne...

How-what-who | Aqua | Acne

Web	www.poombatta.com

Acne: FDA Approved Aczone For Acne Treatment

The U.S. Food and Drug Administration (FDA) approved to market Aczone (dapsone) Gel, 5 per cent for acne vulgaris topical treatment. But patients who have the enzyme deficiency, G6PD (Glucose 6-phosphate dehydrogenase), will need to be monitored with regular blood counts to detect if they are predisposed to one type of anemia (hemolytic anemia).

Aczone, a trademark of QLT USA Inc., is an aqueous topical gel which contains 5 per cent dapsone. According to scientific research, combining dapsone in a Solvent Microparticulate (SMP) gel enables dapsone to be applied topically and safely. This product achieved significant per cent reduction in the number of acne lesions and better success rate on the Global Acne Assessment Score in two randomized double-blind, vehicle controlled clinical studies in 3000 acne patients.

Oiliness/peeling, dryness, and erythema were the most common adverse events reported from controlled clinical trials. However, there were no significant differences in the adverse event rates between Aczone Gel and vehicle control treated patients.

1.4 per cent of about 3500 patients had the enzyme deficiency -in the Aczone clinical trial program- which is consistent with the incidence in the general North American

population.

The company QLT will undertake a post-approval Phase IV study in 50 acne patients who have G6PD deficiency and follow them for 6 months, after which QLT expects to submit an application to the FDA to re-evaluate the Aczone label.

The President and Chief Executive Officer of QLT Inc., Paul Hastings, stated that "Aczone represents an important clinical advance in dermatology, has demonstrated safety and efficacy in over 4,000 patients. We are very pleased with the FDA's decision and confident in Aczone's potential as a new class of treatment for acne patients". Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.

About the author:

Hector Milla, editor of many websites in different topics:Moreover he has a degree in business administration. http://www.disorderskin.com